Dec 29, 2025 • WLNS 6 News
NEUTRAL
Class Action Filed Against Telix Pharmaceuticals Ltd. (TLX) Seeking Recovery for Investors – Contact Levi & Korsinsky
Levi & Korsinsky, LLP has filed a class action securities lawsuit against Telix Pharmaceuticals Ltd. (TLX) on behalf of investors who suffered losses due to alleged securities fraud. The lawsuit claims that Telix overstated the progress of its prostate cancer therapeutic candidates and the quality of its supply chain, leading to materially false and misleading statements. Investors affected between February 21, 2025, and August 28, 2025, have until January 9, 2026, to request lead plaintiff status.
Dec 29, 2025 • ACCESS Newswire
BEARISH
Tune Into the SueWallSt Podcast: Telix Pharmaceuticals Ltd. (TLX) Lawsuit Explained
Levi & Korsinsky, LLP has released a podcast detailing a class action securities lawsuit filed against Telix Pharmaceuticals Ltd. The lawsuit, filed on behalf of investors, alleges that Telix Pharmaceuticals made false and misleading statements regarding the progress of its prostate cancer therapeutic candidates and the quality of its supply chain between February 21, 2025, and August 28, 2025. Investors who suffered losses during this period are encouraged to contact Levi & Korsinsky.
Dec 29, 2025 • PR Newswire
BEARISH
Class Action Filed Against Telix Pharmaceuticals Ltd. (TLX) - January 9, 2026 Deadline to Join - Contact The Gross Law Firm
A class action lawsuit has been filed against Telix Pharmaceuticals Ltd. (TLX) on behalf of shareholders who purchased stock between February 21, 2025, and August 28, 2025. The lawsuit alleges that Telix overstated progress on prostate cancer therapeutic candidates and the quality of its supply chain. Shareholders have until January 9, 2026, to contact The Gross Law Firm to potentially be appointed as lead plaintiff.
Dec 29, 2025 • www.marketscreener.com
BEARISH
TELIX PHARMACEUTICALS LTD. (TLX) Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action
Berger Montague PC has filed a class action lawsuit against Telix Pharmaceuticals Ltd. (NASDAQ: TLX) on behalf of investors who purchased securities between February 21, 2025, and August 28, 2025. The lawsuit alleges that Telix misrepresented its development progress and the reliability of its supply chain, leading to significant losses for investors. Investors have until January 9, 2026, to seek appointment as a lead plaintiff.
Dec 28, 2025 • WRIC ABC 8News
BEARISH
January 9, 2026 Deadline Approaching: Join Class Action Against Telix Pharmaceuticals Ltd. (TLX) - Contact Levi & Korsinsky
A class action lawsuit has been filed against Telix Pharmaceuticals Ltd. (NASDAQ: TLX) for alleged securities fraud between February 21, 2025, and August 28, 2025. Investors who suffered losses on their TLX securities are encouraged to contact Levi & Korsinsky, LLP before the January 9, 2026 deadline. The lawsuit claims Telix made false statements regarding its prostate cancer therapeutic candidates and the quality of its supply chain.
Dec 27, 2025 • WSAV-TV
BEARISH
Burned by Telix Pharmaceuticals Ltd.? Contact Levi & Korsinsky to SueWallSt And Fight Back
Levi & Korsinsky has filed a class-action lawsuit against Telix Pharmaceuticals Ltd. on behalf of investors who experienced losses due to alleged securities fraud between February 21, 2025, and August 28, 2025. The law firm is encouraging affected investors to contact them for assistance. Levi & Korsinsky has a strong track record of winning high-stakes securities litigation cases.